Viewing Study NCT02944058


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-13 @ 7:45 AM
Study NCT ID: NCT02944058
Status: UNKNOWN
Last Update Posted: 2023-08-15
First Post: 2016-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures
Sponsor: University Hospital, Akershus
Organization:

Study Overview

Official Title: Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures. A RCT
Status: UNKNOWN
Status Verified Date: 2023-08
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the project is to compare the management of 3 and 4 part proximal humerus fractures (PHF) with an angular stable plate (Philos) with that of an intramedullary nail (Multiloc) in light of complications, radiological, economical, functional and clinical outcome.
Detailed Description: Randomized controlled trial (RCT) from Akershus University Hospital in Norway. Randomization between two implants. The investigators will use deltopectoral or deltoid split as surgical access. All patients will have calcar screws and cuff sutures. When lack of bone for example after decompressing valgus compressed fractures, a bone-substitute might be used in the surgeons preference. Follow up in outpatient clinic at 6, 12, 52 and 104 weeks, but also a 5 year follow up is planned. Postoperative radiographs of both shoulders and CT of operated shoulder will be taken.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: